Maximizing Efficacy of Antibody–Drug Conjugates


Greg Thurber (left) is an Affiliate Professor on the College of Michigan (MI, USA) based mostly within the Chemical Engineering Division, Biomedical Engineering Division and the Rogel Most cancers Middle. He works with antibody–drug conjugates (ADCs), investigating their distribution inside tumors to enhance their therapeutic index. On this interview from this 12 months’s assembly of the American Affiliation for Most cancers Analysis (Fifth-Tenth April; San Diego, CA, USA), we be taught extra about Thurber’s presentation and analysis on ADCs and the strategies he’s using to boost their therapeutic potential. What have been three key messages out of your presentation? The primary was the significance of intra-tumoral ADC…

To view this content material, please register now for entry

Be part of our member neighborhood for FREE to entry a set of journal and online-only options, together with:

  • Unique entry to academic movies, eBooks and insights into high BioTechniques journal articles
  • The newest information and journal updates delivered straight to your inbox while you need it
  • Customized suggestions for the most recent member-exclusive podcasts, interviews and professional opinions
  • Precedence registration to webinars, panel discussions and occasions
  • Entry to competitions and journal publication reductions, together with 10% off open entry charges while you join at this time!

Hot Topics

Related Articles